Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Rizatriptan
Drug ID BADD_D01957
Description Rizatriptan is a triptan drug used for the treatment of migraine headaches. It is a selective 5-hydroxytryptamine1 receptor subtype agonist.
Indications and Usage For treatment of acute migraine attacks with or without aura.
Marketing Status approved
ATC Code N02CC04
DrugBank ID DB00953
KEGG ID D08485
MeSH ID C093622
PubChem ID 5078
TTD Drug ID D0S9MU
NDC Product Code 33342-088; 71335-1352; 62938-0020; 65977-0067; 33342-087; 63850-7138; 63850-7119
UNII 51086HBW8G
Synonyms rizatriptan | N,N-dimethyl-2-(5-(1,2,4-triazol-1-ylmethyl)-1H-indole-3-yl)ethylamine | rizatriptan benzoate | MK 0462 | MK-0462 | MK-462 | MK 462 | L 705,126 | L-705,126 | L-705126 | L 705126 | Maxalt
Chemical Information
Molecular Formula C15H19N5
CAS Registry Number 144034-80-0
SMILES CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Shock24.06.02.002--Not Available
Skin discolouration23.03.03.0050.000300%Not Available
Sneezing22.12.03.024--
Somnolence19.02.05.003; 17.02.04.0060.000409%
Speech disorder17.02.08.003; 22.12.03.027; 19.19.02.0020.000136%Not Available
Suicide attempt19.12.01.0040.000136%
Supraventricular tachycardia02.03.03.0120.000205%
Swelling08.01.03.015--Not Available
Swollen tongue23.04.01.014; 10.01.05.015; 07.14.02.003--Not Available
Syncope24.06.02.012; 17.02.04.008; 02.11.04.015--
Tachycardia02.03.02.0070.000409%Not Available
Tachypnoea22.02.01.014--Not Available
Tension19.06.02.005--Not Available
Therapeutic response decreased08.06.01.0160.000532%Not Available
Therapeutic response unexpected08.06.01.0010.000300%Not Available
Thirst14.03.02.007; 08.01.09.021--Not Available
Throat tightness19.01.02.005; 22.12.03.0310.000532%Not Available
Thrombosis24.01.01.0060.000136%Not Available
Tinnitus17.04.07.004; 04.04.01.0020.000300%
Tongue disorder07.14.01.002--Not Available
Tongue oedema23.04.01.009; 07.14.02.007; 10.01.05.008--Not Available
Toxic epidermal necrolysis10.01.01.006; 23.03.01.008; 12.03.01.015; 11.07.01.006--
Tremor17.01.06.0020.000641%
Upper respiratory tract infection22.07.03.011; 11.01.13.009--
Urticaria23.04.02.001; 10.01.06.001--
Vasospasm24.04.02.002--Not Available
Ventricular arrhythmia02.03.04.006--
Ventricular fibrillation02.03.04.008--
Ventricular tachycardia02.03.04.010--
Vertigo17.02.12.002; 04.04.01.0030.000573%
The 6th Page    First    Pre   6 7 8    Next   Last    Total 8 Pages